A comparative study of genotoxic effects of anti-topoisomerase II drugs ICRF-193 and bufalin in Chinese hamster ovary cells. (Q40742997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

A comparative study of genotoxic effects of anti-topoisomerase II drugs ICRF-193 and bufalin in Chinese hamster ovary cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Felipe Cortés

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

515

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

171-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11909765%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Eukaryotic DNA topoisomerases I.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

DNA topoisomerase poisons as antitumor drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Catalytic inhibitors of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Etoposide: current status and future perspectives in the management of malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Topoisomerase II: A specific marker for cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

5-Bromodeoxyuridine-dependent increase in sister chromatid exchange formation in Bloom's syndrome is associated with reduction in topoisomerase II activity

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

A simple technique for quantitation of low levels of DNA damage in individual cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

The comet assay: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Different modes of anthracycline interaction with topoisomerase II. Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Synthesis of simian virus 40 C-family catenated dimers in vivo in the presence of ICRF-193.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Involvement of Na+,K(+)-ATPase inhibition in K562 cell differentiation induced by bufalin

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Topoisomerase activities and levels in irradiated Chinese hamster AA8 cells and in its radiosensitive mutant EM9.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

Effects of an inhibitor of topoisomerase II, ICRF-193 on the formation of ultraviolet-induced chromosomal aberrations

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021

A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5718%2802%2900011-6

7 January 2021